The Microsoft AI team has demonstrated that the Microsoft AI Diagnostic Orchestrator (MAI-DxO) can diagnose medical cases correctly up to 85% of the time, which is more than four times better than experienced physicians. With the growing demand for healthcare and rising costs, more people are seeking digital tools for medical advice, resulting in over 50 million health-related sessions daily on Microsoft products. Microsoft is launching a dedicated consumer health initiative by the end of 2024 to develop generative AI solutions that complement their existing healthcare innovations and to ensure trust in AI through robust performance benchmarks.
The Microsoft AI Diagnostic Orchestrator (MAI-DxO) correctly diagnoses up to 85% of NEJM case proceedings, a rate more than four times higher than a group of experienced physicians.
Increasingly, people are turning to digital tools for medical advice and support, evidenced by over 50 million health-related sessions on Microsoft AI consumer products daily.
To instill trust in AI, clinicians and patients must be assured of its performance, which is supported by new benchmarks and the AI orchestrator.
Microsoft is launching a dedicated consumer health effort at the end of 2024 to transform healthcare through generative AI, involving a team of clinicians, designers, and engineers.
Collection
[
|
...
]